US 12,303,514 B2
Immediate and controlled release appetite suppressant compositions for weight loss
Suzanne Bentz, Scottsdale, AZ (US)
Assigned to Red Mountain Med Spa, LLC, Scottsdale, AZ (US)
Filed by Red Mountain Med Spa, LLC, Scottsdale, AZ (US)
Filed on Nov. 3, 2023, as Appl. No. 18/501,814.
Application 18/501,814 is a continuation of application No. 17/733,690, filed on Apr. 29, 2022, granted, now 11,896,598.
Application 17/733,690 is a continuation of application No. 16/808,084, filed on Mar. 3, 2020, granted, now 11,344,556, issued on May 31, 2022.
Prior Publication US 2024/0075043 A1, Mar. 7, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/5377 (2006.01); A61K 9/00 (2006.01); A61K 9/48 (2006.01); A61K 31/135 (2006.01); A61K 47/38 (2006.01); A61K 47/42 (2017.01); A61P 43/00 (2006.01)
CPC A61K 31/5377 (2013.01) [A61K 9/0053 (2013.01); A61K 9/4808 (2013.01); A61K 31/135 (2013.01); A61K 47/38 (2013.01); A61K 47/42 (2013.01); A61P 43/00 (2018.01)] 3 Claims
 
1. An appetite suppressant composition comprising:
from 4.0 wt. % to 16.0 wt. % phentermine hydrochloride;
from 40.0 wt. % to 51.0 wt. % bovine collagen;
from 0.05 wt. % to 0.10 wt. % chromium picolinate and from 35-50% controlled drug releasing agent.